Nihon Kohden Sets New Standard for Central Nursing with the Launch of CNS-2101
18 Dec 2023
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in precision medical devices, is proud to announce the launch of CNS-2101, an innovative new platform designed to enhance efficiency, communication, and patient care.
'With the launch of CNS-2101, we aim to advance central nursing capabilities to better meet evolving health care needs.'
The key features and benefits of CNS-2101 include:
Intuitive Interface: Graphics match Nihon Kohden’s bedside monitors for familiar usability and workflow integration.
Streamlined Data Integration: Seamlessly integrates information into EMRs, pagers, remote viewing apps, and facilitates data sharing between departments.
Flexible Placement: All-in-one system takes up less space than solutions requiring bulky under-counter hardware.
Simplified Setup: No need for complex arrangements to relocate components away from the nursing station.
Eiichi (Eddie) Tanaka, President & CEO of Nihon Kohden America, LLC, said, “With the launch of CNS-2101, we aim to advance central nursing capabilities to better meet evolving health care needs.”
About Nihon Kohden Corporation
Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer, and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe, Asia, and Latin America. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed, and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring, and wireless patient monitoring. For more information, visit us.nihonkohden.com.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.